Administration of certain neuromodulators related to Clostridium botulinum and dermal or soft tissue fillers: Restrictions on use.

1. A dentist who is authorized, pursuant to NRS 454.217 , to inject a neuromodulator that is derived from Clostridium botulinum or that is biosimilar to or the bioequivalent of such a neuromodulator or who is authorized, pursuant to NRS 629.086 , to inject a dermal or soft tissue filler, and who has satisfied the requirements of NAC 631.257 shall not: (a) Administer such an injection to a person other than a patient of record; or (b) Inject such a neuromodulator or filler at an injection site that is outside the oral cavity, maxillofacial area or the adjacent and associated structures of the person. 2. As used in this section, “patient of record” means a person for whom the dentist has, not more than 18 months before the injection of a neuromodulator or filler described in subsection 1: (a) Performed a clinical examination; (b) Completed or evaluated a medical and dental history; (c) Diagnosed an oral condition; and (d) Developed a written plan of treatment.